Chronological changes in the complement system in sepsis

Surgery Today

Volumn 26, Issue 4, 1996, Pages 225-229

  Nakae, Hajime ^a   Endo, Shigeatsu ^a   Inada, Katsuya ^a   Yoshida, Masao ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

chronological change; complement system; sepsis; severity

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A;

ADULT; AGED; ARTICLE; CHRONOLOGY; CLINICAL ARTICLE; COMPLEMENT BLOOD LEVEL; COMPLEMENT HEMOLYSIS TEST; COMPLEMENT SYSTEM; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTENSION; LATEX AGGLUTINATION TEST; MALE; MULTIPLE ORGAN FAILURE; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; BURNS; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT C5A; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT SYSTEM PROTEINS; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PNEUMONIA; POISONING; PROGNOSIS; SEPSIS; SHOCK, SEPTIC; SURVIVAL RATE; TIME FACTORS;

EID: 0029912311     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00311579     Document Type: Article

References (15)

1. Kane MA, May JE, Frank MM (1990) Interaction of the classical and alternative complement pathway with endotoxin in lipopolysaccharide. J Clin Invest 52:370-376
2. Leon C, Rodrigo MJ, Tomasa A, Gallart MT, Latorre FJ, Rius J, Brugues J (1982) Complement activation in septic shock due to gram-negative and gram-positive bacteria. Crit Care Med 10:308-310
3. Sprung CL, Schultz DR, Marcial E, Caralis PV, Gelbard MA, Arnold PI, Long WM (1986) Complement activation in septic shock patients, Crit Care Med 14:525-528
4. Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M (1994) Serum complement levels and severity of sepsis. Res Commun Chem Pathol Pharmacol 84:189-195
5. Langlois PF, Gawryl MS (1988) Accentuated formation of the terminal CSb-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. Am Rev Respir Dis 138:368-375
6. Hack CE, Nuijens JH, Felt-Bersma RJF, Schreuder WO, Eerenberg-Belmer AJM, Paardekooper J, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20-26
7. Chenoweth DE, Hugh TE (1980) Techniques and significance of C3a and C5a measurement. In: Future perspectives in clinical laboratory immunoassays. Nakamura RM, Alan R (eds) Liss, New York, pp 443-460
8. Gorski JP (1981) Quantitation of human complement fragment C4a in physiological fluids by competitive inhibition radioimmunoassay. J Immunol Methods 47:61-73
9. Dofferhoff AS, deJong HJ, Bom VJ, van der Meer J, Limburg PC, de Vries-Hospers HG, Marrink J, Mulder PO, Weits J (1992) Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans. Scand J Infect Dis 24:197-204
10. McCabe WR (1992) Serum complement levels in bacteremia due to gram-negative organisms. New Engl J Med 288:21-23
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
12. Cavaillon JM, Fitting C, Haeffner-Cavaillon N (1990) Recombinant C5a enhances interleukin-1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol 20:253-257
13. Scholz W, McClurg MR, Cardenas GJ, Smith M, Noonan DJ, Hugli TE, Morgan EL (1990) C5a-mediated release of interleukin-6 by human monocytes. Clin Immunol Immunopathol 57:297-307
14. Huey R, Hugli TE (1985) Characterization of a C5a receptor on intact human polymorphonuclear leukocytes (PMN). J Immunol 135:2063-2068
15. Alexander JW, McClellan MA, Ogle CK, Ogli JD (1976) Consumptive opsoninopathy. Ann Surg 184:672-678